In pancreatic cancer, IL-18 promotes tumor progression and metastasis through the NF-κB signaling pathway, with increased NF-κB perpetuating elevated IL-18 expression and forming a positive feedback loop [149, 152]. Here, NFKB1 is linked to neoplasm.